Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stephanie Bowman"'
Autor:
Theresa Diederich, Adam Burdorf, Bunny Pozehl, Stephanie Bowman, Kelly Ferguson, Kyana Holder, Windy Alonso, Douglas Stoller, Scott Lundgren
Publikováno v:
Heartlung : the journal of critical care. 57
Guideline-directed medical therapy (GDMT) reduces mortality and hospitalizations in adults with heart failure with reduced ejection fraction (HFrEF); however, few are receiving GDMT. National registries show as few as 1% of patients are receiving app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c06a330e4ff711c45b2db5b0c4cf0d
https://pubmed.ncbi.nlm.nih.gov/36088681
https://pubmed.ncbi.nlm.nih.gov/36088681
Autor:
Elaine Chow, Stephanie Bowman, Biswajit Kar, Athena Huang, Igor D. Gregoric, Rajko Radovancevic, Phillip Weeks, Sriram Nathan
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2:623-627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::208de7c3cef3c02395cc20c66c86b4c2
https://doi.org/10.1002/jac5.1081
https://doi.org/10.1002/jac5.1081
Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Patients With Stroke
Autor:
Stephanie Bowman, Teresa A. Allison, Heather Hartman, Kiwon Lee, Sara Schepcoff, Brian E Gulbis
Publikováno v:
Journal of Intensive Care Medicine. 34:990-995
Objective: The aim of this study was to determine whether clevidipine (CLEV) achieved faster blood pressure control compared to nicardipine (NIC) in patients presenting with either an acute ischemic stroke (AIS) or a spontaneous intracerebral hemorrh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa56186b224a2af6622da83e53e72b6
https://doi.org/10.1177/0885066617724340
https://doi.org/10.1177/0885066617724340
Autor:
Ronald Zolty, Douglas Stoller, Stephanie Bowman, Theresa Diederich, Bunny Pozehl, Kyana Holder, Marshall Hyden, Scott Lundgren, Adam Burdorf, Brian D. Lowes, Kelly Ferguson
Publikováno v:
Journal of Cardiac Failure. 26:S131-S132
Background While heart failure (HF) is a leading cause of mortality and readmissions, only a small percentage of patients are optimized on guideline-directed medical therapy (GDMT). We developed a multidisciplinary HF clinic to optimize medications,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cdbaf1015bf07255532410a6d72c450
https://doi.org/10.1016/j.cardfail.2020.09.381
https://doi.org/10.1016/j.cardfail.2020.09.381
Publikováno v:
The Annals of pharmacotherapy. 53(2)
Background: Cangrelor is an intravenous P2Y12 receptor antagonist approved for use during percutaneous coronary intervention (PCI) to reduce ischemic events associated with new stent placement and has been used off-label at reduced doses guided by pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46f9a805d6c65385259466c2a56a941
https://pubmed.ncbi.nlm.nih.gov/30132336
https://pubmed.ncbi.nlm.nih.gov/30132336
Autor:
Diederich, Theresa, Lundgren, Scott, Pozehl, Bunny, Ferguson, Kelly, Holder, Kyana, Bowman, Stephanie Bowman, Burdorf, Adam, Lowes, Brian, Zolty, Ronald, Stoller, Douglas, Hyden, Marshall
Publikováno v:
In Journal of Cardiac Failure October 2020 26(10) Supplement:S131-S132
Publikováno v:
The International Journal of Technology, Knowledge, and Society. 5:21-38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47d7a2d5f38b36c755f8a7f5fb7f8bb9
https://doi.org/10.18848/1832-3669/cgp/v05i02/55979
https://doi.org/10.18848/1832-3669/cgp/v05i02/55979